Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella

被引：94

作者：

Miriagou, V

Tassios, PT

Legakis, NJ

Tzouvelekis, LS ^{[1
]}

机构：

[1] Hellenic Pasteur Inst, Bacteriol Lab, Athens, Greece

[2] Univ Athens, Sch Med, Dept Microbiol, Athens 11527, Greece

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2004年 / 23卷 / 06期

关键词：

Salmonella; resistance; cephalosporin;

D O I：

10.1016/j.ijantimicag.2004.03.006

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Expanded-spectrum cephalosporins (ESCs) such as ceftriaxone, together with fluorinated quinolones, are the choice antibiotics in the treatment of invasive salmonella infections. Resistance to ESCs among non-typhoid salmonella has been recognised since the late 1980s. Currently, ESC-resistant salmonella strains are reported world-wide and in some areas their incidence is significant. Resistance is mainly due to acquisition of multi-resistant plasmids encoding a variety of extended- spectrum and AmpC-type beta-lactamases. The origins of ESC-resistant salmonellae are diverse. Exchange of resistance determinants between salmonellae and nosocomial enterobacteria seems to be frequent, at least in developing countries. Also, the use of newer beta-lactams in animal husbandry and veterinary medicine may have facilitated the spread of ESC-resistant salmonella strains in livestock. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

引用

收藏

页码：547 / 555

页数：9

相关论文

共 86 条

[1] Plasmid-mediated TEM-3 extended-spectrum β-lactamase production in Salmonella typhimurium in Casablanca [J].

AitMhand, R ;

Soukri, A ;

Moustaoui, N ;

Amarouch, H ;

ElMdaghri, N ;

Sirot, D ;

Benbachir, M .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) :169-172

[2]

Allen KJ, 2002, CAN J VET RES, V66, P137

[3] Phage types, antibiotic susceptibilities and plasmid profiles of Salmonella typhimurium and Salmonella enteritidis strains isolated in Istanbul, Turkey [J].

Ang-Küçüker, M ;

Tolun, V ;

Helmuth, R ;

Rabsch, W ;

Büyükbaba-Boral, Ö ;

Törümküney-Akbulut, D ;

Susever, S ;

Ang, Ö .

CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (11) :593-599

[4] POSSIBLE INVIVO TRANSFER OF BETA-LACTAMASE TEM-3 FROM KLEBSIELLA-PNEUMONIAE TO SALMONELLA-KEDOUGOU [J].

ARCHAMBAUD, M ;

GERBAUD, G ;

LABAU, E ;

MARTY, N ;

COURVALIN, P .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (04) :427-436

[5] Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production [J].

Armand-Lefèvre, L ;

Leflon-Guibout, V ;

Bredin, J ;

Barguellil, F ;

Amor, A ;

Pagès, JM ;

Nicolas-Chanoine, MH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :1165-1168

[6] Bacterial aetiology and anti-microbial resistance of childhood diarrhoea in Yemen [J].

Banajeh, SM ;

Ba-oum, NHS ;

Al-Sanabani, RMN .

JOURNAL OF TROPICAL PEDIATRICS, 2001, 47 (05) :301-303

[7] Two different extended-spectrum β-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland [J].

Baraniak, A ;

Sadowy, E ;

Hryniewicz, W ;

Gniadkowski, M .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :1095-1097

[8] Characterization of beta-lactamase gene bla(PER-2,) which encodes an extended-spectrum class A beta-lactamase [J].

Bauernfeind, A ;

Stemplinger, I ;

Jungwirth, R ;

Mangold, P ;

Amann, S ;

Akalin, E ;

Ang, O ;

Bal, C ;

Casellas, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :616-620

[9] PERMEABILITY AND PENICILLIN-BINDING PROTEIN ALTERATIONS IN SALMONELLA-MUENCHEN - STEPWISE RESISTANCE ACQUIRED DURING BETA-LACTAM THERAPY [J].

BELLIDO, F ;

VLADOIANU, IR ;

AUCKENTHALER, R ;

SUTER, S ;

WACKER, P ;

THEN, RL ;

PECHERE, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :1113-1115

[10]

BENHASSEN A, 1993, PATHOL BIOL, V41, P706

← 1 2 3 4 5 6 7 8 9 →